South Korean biopharmaceutical company GC Biopharma has signed a contract manufacturing agreement with Curevo Vaccine to produce amezosvatein (development name: CRV-101), a recombinant shingles vaccine currently under clinical development.
In an exclusive interaction with Pharmacy Industrial India, Arushi Jain, Director of Akums Drugs and Pharmaceuticals, shares how the company is redefining pharmaceutical manufacturing through automation, digitalisat...
Arpit Bhatia, Director of Laborate Pharmaceuticals, discusses the company’s forward-looking strategies to broaden its therapeutic portfolio, strengthen global competitiveness, and embrace digital transformatio...
Cold Chain Technologies (CCT) is expanding its footprint in Asia through a series of strategic investments and collaborations. In India, the company has rebranded its regional operations as CCT India and is setting ...
India’s pharmaceutical ecosystem is witnessing a significant transformation across multiple dimensions, opening a wide spectrum of career opportunities for young professionals, particularly pharmacy graduates....
It is essential to deploy an efficient and reliable compressed air dryer throughout the pharmaceutical manufacturing process to eliminate all types of impurities from the compressed air, including water/moisture, du...
India's Tier II and III markets are seeing rapid growth in pharmaceutical demand, improving healthcare access, but also increasing risks like product diversion, unauthorised reselling, and counterfeit drugs—es...
By Darshana Daga
By Pharma Industrial India
Latest news in...
Keywords
Premas Biotech announced the appointment of Saumen Chakraborty to the Premas Biotech Board of Directors. “I am delighte...
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development o...
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy